Corbus Pharmaceuticals Holding (CRBP) — Net Asset Quality Index
Corbus Pharmaceuticals Holding (CRBP) has a Net Asset Quality Index of 84.1% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $109.51 Million minus total liabilities of $17.37 Million yields net assets of $92.15 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check CRBP cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Corbus Pharmaceuticals Holding Net Asset Quality Index Over Time (2012–2024)
This chart shows how Corbus Pharmaceuticals Holding's Net Asset Quality Index has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the index stands at 84.1%, representing net assets of $92.15 Million against total assets of $109.51 Million USD. See how liquid is Corbus Pharmaceuticals Holding's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Corbus Pharmaceuticals Holding (2012–2024)
The table below presents the year-by-year Net Asset Quality Index for Corbus Pharmaceuticals Holding from 2012 to 2024, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Corbus Pharmaceuticals Holding (CRBP) market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 91.4% | $142.43 Million | $155.88 Million | $13.45 Million | ▲ +115.8 pp |
| 2023 | -24.4% | $-6.91 Million | $28.27 Million | $35.18 Million | ▼ -74.2 pp |
| 2022 | 49.7% | $32.99 Million | $66.31 Million | $33.32 Million | ▼ -14.4 pp |
| 2021 | 64.1% | $69.11 Million | $107.73 Million | $38.62 Million | ▲ +19.9 pp |
| 2020 | 44.3% | $45.27 Million | $102.29 Million | $57.02 Million | ▲ +31.7 pp |
| 2019 | 12.5% | $6.16 Million | $49.14 Million | $42.98 Million | ▼ -46.0 pp |
| 2018 | 58.6% | $27.52 Million | $46.99 Million | $19.47 Million | ▼ -27.7 pp |
| 2017 | 86.3% | $57.78 Million | $66.98 Million | $9.19 Million | ▲ +36.4 pp |
| 2016 | 49.9% | $8.92 Million | $17.89 Million | $8.97 Million | ▼ -19.9 pp |
| 2015 | 69.8% | $8.99 Million | $12.88 Million | $3.89 Million | ▼ -19.0 pp |
| 2014 | 88.8% | $5.86 Million | $6.60 Million | $738.04K | ▲ +672.5 pp |
| 2013 | -583.7% | $-1.78 Million | $305.52K | $2.09 Million | ▼ -547.3 pp |
| 2012 | -36.4% | $-198.38 | $544.98 | $743.36 | — |